Results 81 to 90 of about 13,988 (233)

Ultrastructural differences between diabetic and idiopathic gastroparesis [PDF]

open access: yes, 2012
The ultrastructural changes in diabetic and idiopathic gastroparesis are not well studied and it is not known whether there are different defects in the two disorders. As part of the Gastroparesis Clinical Research Consortium, full thickness gastric body
Bernard, Cheryl E.   +36 more
core   +1 more source

Gastroparesis With Multiple Sclerosis [PDF]

open access: yes, 1995
This is a letter to the editor suggesting that gastroparesis be considered as a cause of unexplained upper gastrointestinal tract symptoms in patients with ...
Pender, Michael P.   +2 more
core   +2 more sources

Multi-centric clinical study of the effect of intervention time on efficacy of gastroparesis external application prescription treatment of gastrointestinal tumor postsurgical gastroparesis

open access: yesJournal of Traditional Chinese Medical Sciences, 2016
Objective: This intervention has been shown to be clinically efficacious and safe. The aim of this study was to determine the effect of different intervention times on the efficacy of gastroparesis external application prescription versus placebo for the
Qin Zhou   +9 more
doaj   +1 more source

Light Chain Monoclonal Gammopathy of Undetermined Significance: Diagnosis, Biology, and Clinical Management

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Light chain monoclonal gammopathy of undetermined significance (LC‐MGUS) is defined by an abnormal serum free light chain ratio and elevated involved light chain in the absence of a detectable immunoglobulin heavy chain on immunofixation and of end‐organ damage attributable to a plasma cell disorder.
Sigurður Yngvi Kristinsson   +2 more
wiley   +1 more source

Newly identified human aminoacyl‐tRNA synthetase complex interacting multifunctional protein 2 (AIMP2) loss‐of‐function mutations cause neurodevelopmental defects linked to cell death in a zebrafish model

open access: yesThe FEBS Journal, EarlyView.
Human AIMP2 mutations lead to severe neurodevelopmental defects and brain atrophy. Using patient‐derived fibroblasts from two individuals, we show decreased AIMP2 protein levels and overall protein synthesis. In a zebrafish loss‐of‐function model, the lack of AIMP2 leads to an increase in cell death and results in smaller brains.
Patrick Mullen   +10 more
wiley   +1 more source

Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States [Corrigendum]

open access: yesClinical and Experimental Gastroenterology
Sendzischew Shane MA, Ruddy J, Cline M, Rosenbaum DP, Edelstein S, Moshiree B. Clin Exp Gastroenterol. 2024;17:227–253. The authors have advised that they have identified errors in the reporting of the analysis of one of their previous studies,
Sendzischew Shane MA   +5 more
doaj  

CLINICAL FEATURES AND SEVERITY OF GASTRIC EMPTYING DELAY IN BRAZILIAN PATIENTS WITH GASTROPARESIS

open access: yesArquivos de Gastroenterologia
ContextGastroparesis is defined by delayed gastric emptying without mechanical obstruction of the gastroduodenal junction, which has been increasingly investigated.
Cláudio Marins Rocha BORGES   +2 more
doaj   +1 more source

Real‐world outcomes of zavegepant use in a tertiary care setting using the Migraine Treatment Optimization Questionnaire‐5

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background The introduction of calcitonin gene‐related peptide antagonists has transformed migraine care. Zavegepant, a third‐generation intranasal gepant, offers a nonoral treatment option for acute migraine. Although clinical trials support its efficacy and safety, real‐world data are limited.
Eric Dunn   +5 more
wiley   +1 more source

Dietary modifications achieved successful resolution of symptoms of gastroparesis diagnosed by demonstrating gastric food retention after overnight fasting in diabetic dialysis patients: two case reports with literature review

open access: yesRenal Replacement Therapy, 2020
Background Gastroparesis is frequently overlooked and difficult to treat. The diagnosis of gastroparesis requires standard upper gastrointestinal endoscopy to exclude gastric outlet obstruction and objective evidence demonstrating delayed gastric ...
Eriko Eguchi
doaj   +1 more source

Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature

open access: yes, 2016
There have been a number of agents that have been tried for treatment of gastroparesis over the past 3 decades, with varying levels of success.
Bantu, Likeselam   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy